Does olanzapine have antidepressant properties? A retrospective preliminary study

被引:0
作者
Ghaemi, SN
Cherry, EL
Katzow, JA
Goodwin, FK
机构
[1] Harvard Univ, Bipolar Res Program, Massachusetts Gen Hosp, Consolidated Dept Psychiat, Boston, MA 02114 USA
[2] George Washington Univ, Dept Psychiat, Washington, DC USA
[3] George Washington Univ, Ctr Neurosci Med Progress & Soc, Dept Psychiat, Washington, DC USA
关键词
bipolar disorder; depression; drug therapy; mood disorders; mood stabilizers; olanzapine;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Mood-stabilizing agents are ideally conceptualized as possessing antimanic and antidepressant properties. While research on olanzapine's antimanic effects is growing, data on its possible antidepressant properties are limited. We sought to determine if olanzapine is effective in the add-on treatment of major affective disorders, particularly depressive symptoms, in a naturalistic setting. Methods: All charts of patients meeting DSM-IV criteria for bipolar disorder or unipolar major depressive disorder treated with olanzapine in a private psychiatric practice were reviewed and clinical response was assessed retrospectively using the Clinical Global Impression Scale for Improvement (CGI-I). Results: Olanzapine was moderately effective in 6/10 (60%) patients. Side-effects were present in 8/10 (80%), most commonly weight gain. Conclusions: Olanzapine appears to be moderately effective in open add-on treatment in patients with mainly depressive symptoms. Accumulating evidence suggests that olanzapine, and atypical antipsychotics in general, possess mild to moderate adjunctive antidepressant properties.
引用
收藏
页码:196 / 199
页数:4
相关论文
共 16 条
[1]   Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response [J].
Blier, P ;
Bergeron, R ;
deMontigny, C .
NEUROPSYCHOPHARMACOLOGY, 1997, 16 (05) :333-338
[2]   ANTIDEPRESSANT ACTIVITY AND MANIA ASSOCIATED WITH RISPERIDONE TREATMENT OF SCHIZOAFFECTIVE DISORDER [J].
DWIGHT, MM ;
KECK, PE ;
STANTON, SP ;
STRAKOWSKI, SM ;
MCELROY, SL .
LANCET, 1994, 344 (8921) :554-555
[3]  
Hertel P, 1997, NEUROPSYCHOPHARMACOL, V17, P44
[4]   RISPERIDONE IN THE TREATMENT OF DISORDERS WITH A COMBINED PSYCHOTIC AND DEPRESSIVE SYNDROME - A FUNCTIONAL-APPROACH [J].
HILLERT, A ;
MAIER, W ;
WETZEL, H ;
BENKERT, O .
PHARMACOPSYCHIATRY, 1992, 25 (05) :213-217
[5]  
KECK PE, 1995, J CLIN PSYCHIAT, V56, P466
[6]  
Koenig F, 1998, ANN M AM PSYCH ASS T
[7]  
LONDON J, 1998, J AM ACAD CHILD ADOL, V37, P997
[8]   Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome [J].
Müller-Siecheneder, F ;
Müller, MJ ;
Hillert, A ;
Szegedi, A ;
Wetzel, H ;
Benkert, O .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (02) :111-120
[9]  
ROTHSCHILD A, 1997, 36 AM COLL NEUR WAIK
[10]   Bipolar mood disorder: Practical strategies for acute and maintenance phase treatment [J].
Sachs, GS .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1996, 16 (02) :S32-S47